A detailed history of Nisa Investment Advisors, LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 71 shares of KOD stock, worth $590. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71
Previous 48 47.92%
Holding current value
$590
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$2.2 - $3.25 $50 - $74
23 Added 47.92%
71 $0
Q2 2024

Jul 19, 2024

BUY
$2.29 - $4.48 $73 - $143
32 Added 200.0%
48 $0
Q1 2024

May 01, 2024

BUY
$3.01 - $7.45 $48 - $119
16 New
16 $0
Q3 2023

Nov 02, 2023

BUY
$1.8 - $7.49 $108 - $449
60 Added 4.86%
1,295 $2,000
Q2 2023

Aug 11, 2023

SELL
$4.3 - $9.48 $185,222 - $408,351
-43,075 Reduced 97.21%
1,235 $8,000
Q1 2023

May 02, 2023

SELL
$4.81 - $8.88 $78,999 - $145,845
-16,424 Reduced 27.04%
44,310 $275,000
Q4 2022

Feb 02, 2023

BUY
$6.52 - $8.05 $93,555 - $115,509
14,349 Added 30.93%
60,734 $435,000
Q2 2022

Aug 03, 2022

BUY
$5.04 - $9.48 $78,624 - $147,888
15,600 Added 50.67%
46,385 $354,000
Q1 2022

Apr 29, 2022

BUY
$7.09 - $89.45 $209,509 - $2.64 Million
29,550 Added 2392.71%
30,785 $238,000
Q4 2021

Feb 03, 2022

SELL
$80.85 - $128.49 $30,318 - $48,183
-375 Reduced 23.29%
1,235 $72,000
Q3 2021

Oct 18, 2021

BUY
$81.97 - $106.94 $30,738 - $40,102
375 Added 30.36%
1,610 $155,000
Q1 2021

Apr 26, 2021

BUY
$110.45 - $164.47 $11,045 - $16,447
100 Added 8.81%
1,235 $140,000
Q4 2020

Jan 25, 2021

SELL
$60.78 - $154.03 $3,039 - $7,701
-50 Reduced 4.22%
1,135 $167,000
Q3 2020

Oct 20, 2020

BUY
$45.05 - $59.27 $38,292 - $50,379
850 Added 253.73%
1,185 $70,000
Q2 2020

Jul 27, 2020

BUY
$42.74 - $66.25 $4,060 - $6,293
95 Added 39.58%
335 $18,000
Q1 2020

Apr 17, 2020

BUY
$38.18 - $73.95 $9,163 - $17,748
240 New
240 $11,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $433M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.